SCHEMBL22112401

SCHEMBL22112401

COCCN(CC(O)O)C(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.34
KDM4E B2RXH2 4/20 0.33
MDM2 Q00987 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ALDH1A1 P00352 5/20 0.33
TDP1 Q9NUW8 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
SLC6A9 P48067 1/20 0.31
S1PR1 P21453 1/20 0.31
RIPK1 Q13546 1/20 0.30
ABL1 P00519 1/20 0.30
RIN1 Q13671 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199969 0.85 SIGMAR1 (0.35) SIGMAR1KDM4EMDM2HSD17B10ALDH1A1
SCHEMBL20200038 0.81 KDM4E (0.39) SIGMAR1KDM4EMDM2HSD17B10ALDH1A1
SCHEMBL22112422 0.77 HSD17B10 (0.34) KDM4EHSD17B10ALDH1A1TDP1SMN1; SMN2
SCHEMBL20199971 0.76 ALDH1A1 (0.35) SIGMAR1KDM4EMDM2HSD17B10ALDH1A1
SCHEMBL22069505 0.76 HSD17B10 (0.37) KDM4EHSD17B10ALDH1A1TDP1SMN1; SMN2
SCHEMBL22069385 0.75 SIGMAR1 (0.33) SIGMAR1KDM4EMDM2HSD17B10ALDH1A1
SCHEMBL20199838 0.75 HSD17B10 (0.33) KDM4EHSD17B10ALDH1A1TDP1SMN1; SMN2
SCHEMBL2009423 0.73 SIGMAR1 (0.61) SIGMAR1ALDH1A1TDP1
SCHEMBL20200027 0.72 HSD17B10 (0.39) SIGMAR1KDM4EMDM2HSD17B10ALDH1A1
SCHEMBL22403101 0.72 HSD17B10 (0.35) KDM4EHSD17B10ALDH1A1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544964-B1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING Bayer Pharma AG (DE) 2020-06-17 EP disclosed